SARS-CoV-2 ORF7a Blocking Peptide
Catalog no. P-SARS-COV2-ORF7A · Research Use Only
$155 per 250 µg. Ships within 2–3 business days from the U.S.
P-SARS-COV2-ORF7A — affinity-purified Rabbit antibody against COVID19 ORF7a. Validated for Immunodepletion, Immunocompetition.
Specifications
| Catalog number | P-SARS-COV2-ORF7A |
|---|---|
| Target | COVID19 ORF7a |
| Applications | Immunodepletion, Immunocompetition |
| Conjugate | Unconjugated |
| Immunogen | Synthetic peptide taken from unique amino acid sequence on ORF7a [Severe acute respiratory syndrome coronavirus 2]. |
| Size | 250 µg |
| Storage | -20°C |
About this target
SARS-CoV-2 ORF7a Blocking Peptide is the antigenic blocking peptide for the COVID19 ORF7a antibody SARS-COV2-ORF7A-101AP. Pre-incubating the antibody with the peptide competes away specific binding, which helps confirm that a signal comes from the intended target. Supplied at 250 µg, for research use only.
Documents
Related products
- SARS-CoV-2 ORF7a Positive Control (PC-SARS-COV2-ORF7A)
- SARS-CoV-2 ORF7a Antibody (SARS-COV2-ORF7A-101AP)
- SARS-CoV-2 ORF7a Antibody BIOTIN (SARS-COV2-ORF7A-BIOTIN)
- SARS-CoV-2 ORF7a Antibody FITC (SARS-COV2-ORF7A-FITC)
FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.